Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 Jan 1994

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Research Studies

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 7904666
DOI: 10.1016/s0140-6736(94)90988-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of inductionPMID 7904666Read ↗

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemiaSemantic proximity Read ↗

NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocolSemantic proximity Read ↗

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarraysSemantic proximity Read ↗

Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaSemantic proximity Read ↗

A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groupsSemantic proximity Read ↗

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingSemantic proximity Read ↗

Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01Semantic proximity Read ↗

Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemiaSemantic proximity Read ↗

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.Semantic proximity Read ↗

Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profilingSemantic proximity Read ↗

Childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.